Thermo Fisher Scientific (TMO) revenue

Revenue · fiscal 2025
$44.56B

Thermo Fisher Scientific (TMO) reported revenue of $44.56B in fiscal 2025 (the year ended December 31, 2025). That is 3.9% higher than the $42.88B of fiscal 2024. Figures as of 18 Nov 2026, 11:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$44.56B
Change on fiscal 2024
+3.9%
Growth, 5 years
+6.7% a year
Growth, 10 years
+10.1% a year
Highest on record
$44.92Bfiscal 2022
Lowest on record
$9.75Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Thermo Fisher Scientific revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 6.7% a year; over ten years the rate was 10.1% a year. Across the 19 fiscal years on record (2007–2025), the highest was $44.92B in fiscal 2022 and the lowest $9.75B in fiscal 2007.

History · 19 fiscal years

Revenue by fiscal year

Thermo Fisher Scientific revenue, year by year

Thermo Fisher Scientific (TMO) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$44.56B 3.9% up
2024$42.88B 0.1% up
2023$42.86B 4.6% down
2022$44.92B 14.5% up
2021$39.21B 21.7% up
2020$32.22B 26.1% up
2019$25.54B 4.9% up
2018$24.36B 16.4% up
2017$20.92B 14.5% up
2016$18.27B 7.7% up
2015$16.97B 0.4% up
2014$16.89B 29.0% up
2013$13.09B 4.6% up
2012$12.51B 8.2% up
2011$11.56B 11.2% up
2010$10.39B 4.9% up
2009$9.91B 5.6% down
2008$10.50B 7.7% up
2007$9.75B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Thermo Fisher Scientific and comparable companies
CompanyRevenueFiscal year
UnitedHealth Group UNH$447.57B2025
Novartis NVS$56.67B2025
AstraZeneca AZN$58.74B2025
Thermo Fisher Scientific TMO$44.56B2025
Amgen AMGN$36.75B2025
Gilead Sciences GILD$29.44B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TMO

Thermo Fisher Scientific, figure by figure

Thermo Fisher Scientific (TMO) overview: price, valuation and scorecardAll health care companies by market value

Thermo Fisher Scientific revenue: questions and answers

What is Thermo Fisher Scientific's revenue?

Thermo Fisher Scientific (TMO) reported revenue of $44.56B in fiscal 2025 (the year ended December 31, 2025). That is 3.9% higher than the $42.88B of fiscal 2024.

What is the growth rate of Thermo Fisher Scientific's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 6.7% a year; over ten years the rate was 10.1% a year.

What are the highest and lowest revenue figures on record for Thermo Fisher Scientific?

Across the 19 fiscal years on record (2007–2025), the highest was $44.92B in fiscal 2022 and the lowest $9.75B in fiscal 2007.

How is Thermo Fisher Scientific's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Thermo Fisher Scientific it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Thermo Fisher Scientific (TMO) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/TMO/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.